Please sign in to follow a disease.
Systemic mycosis
MONDO:0000256A mycosis that involves the lungs, abdominal viscera, bones and or central nervous system.
Also known as: systemic fungal infection
55 clinical trials for this condition and its sub-types, 27 tagged with Systemic mycosis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Systemic mycosis
-
Opportunistic systemic mycosis 0 trials · 23 incl. sub-types
3 sub-types
- Disseminated candidiasis 16 trials
- Penicilliosis 5 trials
- Trichosporonosis 0 trials · 2 incl. sub-types Sub-types →
-
Primary systemic mycosis 0 trials · 9 incl. sub-types
6 sub-types
- Histoplasmosis 5 trials · 6 incl. sub-types Sub-types →
- Coccidioidomycosis 4 trials
- Blastomycosis 1 trial
- Adiaspiromycosis 0 trials
- Allescheriosis 0 trials
- Paracoccidioidomycosis 0 trials
-
Disseminated sporotrichosis 0 trials
Most studied deeper sub-types
-
New pill could fight dangerous fungal infections
Disease control Stopped earlyThis study tested a new oral antifungal drug, ibrexafungerp, for treating serious Candida infections in the blood or internal organs. 68 adults received an IV antifungal followed by either ibrexafungerp or standard oral fluconazole. The trial was stopped early, so the results are…
Phase 3 • Sponsor: Scynexis, Inc. • Aim: Disease control
Last updated Aug 12, 2026 00:00 UTC
-
New hope against deadly molds? early trial cut short
Disease control Stopped earlyThis study tested a drug called fosmanogepix in 21 adults with invasive mold infections (like Aspergillus or rare molds) who had few other options. The trial was stopped early, so we have limited data on how well it works or its safety.
Phase 2 • Sponsor: Basilea Pharmaceutica • Aim: Disease control
Last updated Jun 26, 2026 17:54 UTC